Pimavanserin
22-02-723-205
Phase 1 small_molecule terminated
Quick answer
Pimavanserin for Parkinson Disease is a Phase 1 program (small_molecule) at ACADIA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ACADIA PHARMACEUTICALS INC
- Indication
- Parkinson Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated